SCHEMBL9913834

SCHEMBL9913834

CC(C)(C)OC(=O)N[C@H]1C[C@H](Oc2cccc(Cl)c2Cl)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.49
DRD3 P35462 1/20 0.48
REN P00797 1/20 0.48
KMT2A Q03164 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM1A O60341 1/20 0.42
MAOB P27338 1/20 0.42
EPHX2 P34913 1/20 0.42
BTK Q06187 3/20 0.41
CACNB4 O00305 1/20 0.40
CACNA1A O00555 1/20 0.40
CACNA1G O43497 1/20 0.40
CACNG3 O60359 1/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1H O95180 1/20 0.40
CACNB3 P54284 1/20 0.40
CACNA2D1 P54289 1/20 0.40
CACNG7 P62955 1/20 0.40
CACNA1B Q00975 1/20 0.40
CACNA1D Q01668 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9913653 1.00 DRD2 (0.49) DRD2DRD3RENKMT2AL3MBTL1
SCHEMBL9913886 0.86 KMT2A (0.43) DRD2DRD3RENKMT2AL3MBTL1
SCHEMBL9278580 0.82 P2RX7 (0.42) KMT2AL3MBTL1EPHX2P2RX7
SCHEMBL9278476 0.82 P2RX7 (0.42) KMT2AL3MBTL1EPHX2P2RX7
SCHEMBL9278473 0.82 P2RX7 (0.42) KMT2AL3MBTL1EPHX2P2RX7
SCHEMBL29874413 0.81 SLC6A2 (0.45) DRD2KMT2AL3MBTL1KDM1AMAOB
SCHEMBL9913822 0.80 KMT2A (0.42) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL30213340 0.79 KMT2A (0.49) DRD2KMT2AL3MBTL1KDM1AMAOB
SCHEMBL9913652 0.78 KMT2A (0.46) DRD2KMT2AL3MBTL1KDM1AMAOB
SCHEMBL9913805 0.77 KDM1A (0.47) KMT2AL3MBTL1KDM1AMAOBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012072512-A1 N-CYCLOBUTYL-IMIDAZOPYRIDINE OR -PYRAZOLOPYRIDINE CARBOXAMIDES AS TRPV1 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2012-06-07 WO disclosed